The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients.

Marco VicenziMassimiliano RuscicaSimona IodiceIrene RotaAngelo RattiRoberta Di CosolaAlberto CorsiniValentina Bollati Stefano Aliberti Francesco Blasi

Published in: Journal of clinical medicine (2020)

The novelty of our observation relies on the independent positive impact of canrenone on the all-cause mortality and clinical improvement of COVID-19 patients ranging from moderate to severe diseases.

Keyphrases

sars cov
early onset
high intensity